Clinical Studies
Breast Care
Cardiology
Colon Cancer
Dermatology
Diabetes
Gastrointestinal
HIV/AIDS
Mental Health
Neurology
NeuroOphthalmology
Obesity/Weight Management
Women's Health
Other
Special Features
Advances/Research
| Principal Investigator: | Andrew Alexis, MD | |
| Co-investigators: | Marcelyn Coley, MD |
|
| Time frame of study: | Ongoing | |
| Time frame of participation: | Approximately 12 months | |
| Number of participants needed: | 20 | |
| Location of Study: | St. Luke’s-Roosevelt Hospital
Center |
|
| Contact Name, Number & Email: | Clinical Research Offiice (212) 523-4511 MColey@chpnet.org |
Summary:
This is a multi-center, open-label, randomized, prospective
study to compare the efficacy of four anti-inflammatory treatment regimens
for the hair loss disorder, central centrifugal cicatricial alopecia (CCCA).
The 48-week study will be divided into 2 phases: a 24 week Anti-Inflammatory
phase (Phase 1) followed by a 24 week Stimulation of Growth phase (Phase
2). 20 female subjects will be recruited at each of 3 sites. Subjects
will be followed for a minimum of 48 weeks with interval visit assessments
after treatment is initiated for a minimum of 10 visits.
Criteria for
Participation:
-Female patients of African descent
-Ages 18-65
-Progressive hair loss that began on top, central part of the scalp
Benefits/Compensation:
Evaluation and treatment by a board
certified dermatologist